| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/01/2012 | EP2481415A1 Activin-ActRIIa Antagonists and Uses for Promoting Bone Growth in Cancer Patients |
| 08/01/2012 | EP2481409A2 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 08/01/2012 | EP2481405A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 08/01/2012 | EP2481404A1 An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |
| 08/01/2012 | EP2481402A2 Nanoparticle comprising rapamycin and albumin as anticancer agent |
| 08/01/2012 | EP2481396A2 Oxaliplatin nanoparticles and method for preparing same |
| 08/01/2012 | EP2480687A1 Methods and compositions for the diagnosis and treatment of thyroid cancer |
| 08/01/2012 | EP2480668A2 Compositions and methods for silencing genes expressed in cancer |
| 08/01/2012 | EP2480579A2 Methods of treating inflammation |
| 08/01/2012 | EP2480575A1 Antagonists of dsg2 for treatment of cancer |
| 08/01/2012 | EP2480573A1 Treating cancer by modulating mex-3 |
| 08/01/2012 | EP2480563A2 Bladder cancer specific ligand peptides |
| 08/01/2012 | EP2480554A1 Macrocyclic inhibitors of jak |
| 08/01/2012 | EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors |
| 08/01/2012 | EP2480543A1 Piperidine and piperazine derivatives as smo antagonists |
| 08/01/2012 | EP2480535A1 Polymorphs of sorafenib acid addition salts |
| 08/01/2012 | EP2480528A1 Lysine specific demethylase-1 inhibitors and their use |
| 08/01/2012 | EP2480257A2 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13) |
| 08/01/2012 | EP2480230A2 Dr5 ligand drug conjugates |
| 08/01/2012 | EP2480207A2 Micelle encapsulation of therapeutic agents |
| 08/01/2012 | EP2480084A1 Combination |
| 08/01/2012 | EP2285817B1 Novel uses of d-mannopyranose derivatives activating angiogenesis |
| 08/01/2012 | EP2242757B1 Pyrazolopyridines as kinase inhibitors |
| 08/01/2012 | EP2155335B1 Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition |
| 08/01/2012 | EP2155201B1 Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of janus kinases |
| 08/01/2012 | EP2032535B1 Spirocyclic nitriles as protease inhibitors |
| 08/01/2012 | EP1986625B1 Treatment of ovarian cancer |
| 08/01/2012 | EP1971604B1 Pyrrolo-pyridine derivatives for the treatment of cancer diseases |
| 08/01/2012 | EP1896040B1 Phosphoramidate alkylator prodrugs |
| 08/01/2012 | EP1888543B1 Apoptosis promoters |
| 08/01/2012 | EP1885337B1 Medicament, particularly an anti-cancer medicament, for treatment using immunotherapy, particularly autologous |
| 08/01/2012 | EP1848718B1 Inhibitors of e1 activating enzymes |
| 08/01/2012 | EP1819697B1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/01/2012 | EP1797183B1 Regulation of oncogenes by micrornas |
| 08/01/2012 | EP1734918B1 Pharmaceutical composition for treating hair loss and benign prostatic hyperplasia |
| 08/01/2012 | EP1333853B1 Growth factor complex |
| 08/01/2012 | EP1328653B1 Highly expressible genes |
| 08/01/2012 | EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 08/01/2012 | EP1133310B1 Artery- and vein-specific proteins and uses therefor |
| 08/01/2012 | EP0961612B2 Protein stabilized pharmacologically active agents and their use |
| 08/01/2012 | CN1993333B Triazole derivative |
| 08/01/2012 | CN102625836A Nucleic acid molecule capable of binding to HMGB1, and use thereof |
| 08/01/2012 | CN102625813A Immunoglobulins with reduced aggregation |
| 08/01/2012 | CN102625808A Spirocyclic amide derivatives |
| 08/01/2012 | CN102625807A 4-substituted pyridin-3-yl-carboxamide compounds and methods of use |
| 08/01/2012 | CN102625805A Compounds and compositions for treating cancer |
| 08/01/2012 | CN102625804A Compounds useful for treating AIDS |
| 08/01/2012 | CN102625798A Substituted quinolines for use as VEGF inhibitors |
| 08/01/2012 | CN102625797A Substituted heterocyclic compounds as kinases inhibitors and method of use thereof |
| 08/01/2012 | CN102625711A Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides |
| 08/01/2012 | CN102621243A Fingerprint spectrum of henbane medicinal material and method for controlling quality of henbane medicinal material |
| 08/01/2012 | CN102618612A Preparation method for black-bone chicken peptide for chemotherapy, attenuation and synergia and application of black-bone chicken peptide |
| 08/01/2012 | CN102618577A Enhanced tumor-specific therapy vector |
| 08/01/2012 | CN102618567A pET15b-PEP-1-VP3 plasmids, construction method of the pET15b-PEP-1-VP3 plasmids, PEP-1-VP3 fusion protein and expression method of the PEP-1-VP3 fusion protein |
| 08/01/2012 | CN102618547A Nucleic acid aptamer rich in guanine |
| 08/01/2012 | CN102618545A Gene involved in immortalization of human cancer cell and use thereof |
| 08/01/2012 | CN102618452A Preparation method, composition and application of lactobacillus salivarius and its metabolites |
| 08/01/2012 | CN102618448A Drimane-type sesquialter terpene cyclohexenone derivative, preparation method thereof and application |
| 08/01/2012 | CN102618424A Acanthopanax brachypus life prolonging wine |
| 08/01/2012 | CN102617736A The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer |
| 08/01/2012 | CN102617734A Antibody Dab-2 against FGF-2 and application thereof |
| 08/01/2012 | CN102617718A Bran coat antitumor active protein, as well as preparation method and applications thereof |
| 08/01/2012 | CN102617707A New homologue 2-methyl-actinomycin D of actinomycin D and its preparation method |
| 08/01/2012 | CN102617698A Method for preparing fine dioscin and application of fine dioscin |
| 08/01/2012 | CN102617679A Preparation method and application of connected conjugated linoleic acid and gemcitabine prodrug |
| 08/01/2012 | CN102617676A Zidovudine quinoline conjugated compound, preparation method thereof and application for liver cancer resistance |
| 08/01/2012 | CN102617672A Camellia nitidissima flavonoid glycoside, and preparation method and application thereof |
| 08/01/2012 | CN102617664A Plumbagin-5-O-glucose and synthetic method and application thereof |
| 08/01/2012 | CN102617642A Biphosphate compound containing2-ethyl imidazole as well as preparation method and application thereof |
| 08/01/2012 | CN102617632A Organic germanium complex, and preparation method and application thereof |
| 08/01/2012 | CN102617610A Preparation method of porphyrin photosensitizer and anticarcinogen diad |
| 08/01/2012 | CN102617609A Indole alkaloid compound, its analog, its medicinal composition, and its use |
| 08/01/2012 | CN102617599A Macrocyclic compound and application thereof |
| 08/01/2012 | CN102617596A Dimeric sesquiterpene compound Hippolide I, its preparation method and its purpose |
| 08/01/2012 | CN102617588A Anti-tumor compound, and preparation method and application thereof |
| 08/01/2012 | CN102617584A Irinotecan hydrochloride compound and medicinal composition thereof |
| 08/01/2012 | CN102617582A Triazole epothilone analogue, drug composition thereof, preparation method of triazole epothilone and application |
| 08/01/2012 | CN102617580A Vasopressin V1a Antagonists |
| 08/01/2012 | CN102617578A Imidazole derivative and medicine application thereof |
| 08/01/2012 | CN102617573A 9-substituted triazole para-naphthalimide derivative, preparation method thereof and application |
| 08/01/2012 | CN102617569A Beta-carboline derivative having antitumor activity and preparation method thereof |
| 08/01/2012 | CN102617564A Compound and preparation method thereof |
| 08/01/2012 | CN102617563A Compound and preparation method thereof |
| 08/01/2012 | CN102617546A Aromatic iodonium salts as NADH oxidase inhibitors and anti-tumor application thereof |
| 08/01/2012 | CN102617538A Xanthone type small molecule with effect of broad spectrum regulation on micro ribonucleic acid and synthesis method and application thereof |
| 08/01/2012 | CN102617536A Isoflavone compound, its preparation method, and its application in preparation of antiviral or antitumor drugs |
| 08/01/2012 | CN102617526A Dimeric sesquiterpene compound Hippolide J, its preparation method and its purpose |
| 08/01/2012 | CN102617521A Gamma-butyrolactone polyketone compounds having antineoplastic activity |
| 08/01/2012 | CN102617517A Novel 7,10-O,O-dimethyl docetaxel derivatives and use thereof |
| 08/01/2012 | CN102617502A Benzoxazole derivatives and application of benzoxazole derivatives to medicines |
| 08/01/2012 | CN102617480A Di-(hetero)aryl-substituted tertiary amine compounds, preparation method thereof and antitumor application thereof |
| 08/01/2012 | CN102617478A Synthesis of benzimidazole, oxazole and thiazole derivatives and application thereof |
| 08/01/2012 | CN102617459A 1, 4-dihydroxy-2-formoxyl-9, 10 anthraquinone new acyl hydrazone compounds with antitumor activity and preparation method |
| 08/01/2012 | CN102617443A Optically active indole derivative, synthetic method and application thereof |
| 08/01/2012 | CN102617442A Preparation method and use of 3,3'-methylenebis(1H-Indole) |
| 08/01/2012 | CN102617435A Leucosceptrum canum chinone, preparation method and application |
| 08/01/2012 | CN102617391A Resveratrol benzene acrylamide derivative, preparing method and application thereof |
| 08/01/2012 | CN102617342A (+/-)-alkannin naphthazarin parent nucleus oxygen alkyl acylation derivant and preparation method thereof |
| 08/01/2012 | CN102614529A Drug delivery system for treating nasopharyngeal carcinoma (NPC) and construction method and application method thereof |
| 08/01/2012 | CN102614528A Polyconjugates for in vivo delivery of polynucleotides |